Sex- and Age-Specific Optimal Anthropometric Indices as Screening Tools for Metabolic Syndrome in Chinese Adults
Table 4
AUCs, optimal cut-off points, and sensitivities and specificities of the cut-off points of the anthropometric indices for predicting cardiometabolic risk factors in the ROC analyses.
Components
BMI
WC
WHtR
ABSI
BRI
CI
AUC (95% CI)
Cut-off
Sen Spe
AUC (95% CI)
Cut-off
Sen Spe
AUC (95% CI)
Cut-off
Sen Spe
AUC (95% CI)
Cut-off
Sen Spe
AUC (95% CI)
Cut-off
Sen Spe
AUC (95% CI)
Cut-off
Sen Spe
Women
Hypertension
0.738ac (0.728–0.748)
23.18
0.704 0.663
0.752ab (0.743–0.762)
78.20
0.706 0.647
0.769abc (0.761–0.778)
0.498
0.715 0.694
0.648abc (0.638–0.659)
0.0758
0.682 0.537
0.769abc (0.761–0.778)
3.33
0.717 0.694
0.711abc (0.701–0.721)
1.190
0.660 0.657
Diabetes/IFG
0.699a (0.693–0.705)
23.82
0.692 0.606
0.710a (0.704–0.716)
79.25
0.606 0.704
0.722abc (0.716–0.727)
0.490
0.695 0.633
0.626abc (0.520–0.632)
0.0769
0.561 0.627
0.722abc (0.716–0.727)
3.18
0.695 0.633
0.676abc (0.670–0.682)
1.180
0.656 0.601
High TG
0.729ac (0.723–0.734)
23.00
0.690 0.655
0.741ab (0.735–0.747)
77.25
0.713 0.647
0.752abc (0.746–0.758)
0.489
0.725 0.652
0.638abc (0.632–0.644)
0.0770
0.556 0.651
0.752abc (0.746–0.758)
3.16
0.725 0.652
0.697ac (0.691–0.703)
1.173
0.711 0.585
Low HDL-C
0.644a (0.637–0.650)
22.21
0.613 0.601
0.643a (0.637–0.649)
75.75
0.599 0.612
0.643a (0.637–0.650)
0.473
0.624 0.589
0.564abc (0.558–0.571)
0.0746
0.640 0.458
0.643a (0.637–0.650)
2.87
0.624 0.589
0.603abc (0.597–0.609)
1.143
0.684 0.465
High LDL-C
0.628ac (0.622–0.634)
22.29
0.643 0.543
0.635ab (0.629–0.641)
76.75
0.608 0.597
0.645abc (0.639–0.652)
0.474
0.678 0.533
0.577abc (0.570–0.583)
0.0764
0.515 0.599
0.645abc (0.639–0.652)
2.89
0.678 0.533
0.611abc (0.605–0.617)
1.173
0.594 0.576
Hyperuricemia
0.722a (0.716–0.728)
22.96
0.729 0.607
0.724a (0.718–0.730)
79.25
0.657 0.683
0.728a (0.722–0.733)
0.502
0.665 0.675
0.609abc (0.603–0.615)
0.0759
0.636 0.532
0.728a (0.722–0.733)
3.39
0.665 0.675
0.671abc (0.655–0.677)
1.187
0.643 0.615
NAFLD
0.837ac (0.833–0.842)
23.26
0.806 0.718
0.831ab (0.826–0.836)
78.45
0.795 0.715
0.832ab (0.827–0.836)
0.498
0.782 0.732
0.643abc (0.636–0.649)
0.0763
0.612 0.599
0.832ab (0.827–0.837)
3.33
0.782 0.732
0.738abc (0.732–0.744)
1.182
0.716 0.644
Men
Hypertension
0.667ac (0.662–0.672)
24.75
0.705 0.542
0.673ab (0.668–0.678)
88.25
0.662 0.584
0.690abc (0.685–0.695)
0.524
0.665 0.614
0.586abc (0.581–0.591)
0.0790
0.604 0.523
0.690abc (0.685–0.695)
3.81
0.665 0.614
0.643abc (0.638–0.648)
1.243
0.647 0.562
Diabetes/IFG
0.649ac (0.644–0.654)
24.79
0.668 0.546
0.658ab (0.653–0.663)
89.90
0.594 0.637
0.667abc (0.662–0.672)
0.526
0.610 0.629
0.580abc (0.575–0.585)
0.0800
0.493 0.624
0.667abc (0.662–0.672)
3.86
0.610 0.629
0.630abc (0.652–0.635)
1.247
0.597 0.592
High TG
0.686a (0.681–0.691)
24.32
0.720 0.553
0.688a (0.683–0.693)
85.80
0.761 0.515
0.689a (0.684–0.694)
0.504
0.763 0.516
0.570abc (0.565–0.575)
0.0789
0.584 0.524
0.689a (0.684–0.694)
3.44
0.763 0.516
0.634abc (0.629–0.639)
1.227
0.688 0.509
Low HDL-C
0.641ac (0.636–0.646)
24.24
0.687 0.520
0.636ab (0.631–0.641)
85.80
0.712 0.496
0.632abc (0.627–0.637)
0.510
0.662 0.534
0.535abc (0.529–0.540)
0.0775
0.689 0.363
0.632abc (0.627–0.637)
3.55
0.662 0.534
0.584abc (0.579–0.589)
1.233
0.612 0.512
High LDL-C
0.567a (0.562–0.573)
23.60
0.728 0.373
0.565a (0.560–0.570)
84.75
0.715 0.383
0.569ac (0.564–0.574)
0.494
0.755 0.358
0.524abc (0.519–0.530)
0.0780
0.644 0.396
0.569ac (0.564–0.574)
3.24
0.755 0.358
0.547abc (0.542–0.552)
1.207
0.743 0.331
Hyperuricemia
0.649a (0.644–0.654)
25.14
0.638 0.580
0.646a (0.641–0.651)
86.25
0.740 0.472
0.638abc (0.633–0.643)
0.503
0.784 0.414
0.532abc (0.527–0.538)
0.0789
0.566 0.485
0.638abc (0.633–0.643)
3.41
0.781 0.418
0.588abc (0.583–0.593)
1.220
0.728 0.403
NAFLD
0.770ac (0.766–0.775)
24.87
0.721 0.692
0.763ab (0.759–0.767)
87.75
0.733 0.666
0.757abc (0.752–0.761)
0.513
0.748 0.640
0.572abc (0.566–0.577)
0.0784
0.640 0.471
0.757abc (0.752–0.761)
3.59
0.749 0.638
0.666abc (0.661–0.671)
1.231
0.685 0.557
AUC: area under the curve; ROC: receiver-operating characteristic; BMI: body mass index; WC: waist circumference; WHtR: waist-to-height ratio; ABSI: a body shape index; BRI: body roundness index; CI: conicity index; 95% CI: 95% confidence interval; Sen: sensitivity; Spe: specificity; IFG: impaired fasting glucose; TG: triglycerides; HDL-C: high-density lipoprotein cholesterol; LDL-C: low-density lipoprotein cholesterol; NAFLD: nonalcoholic fatty liver. AUC in the ROC analysis, . Hanley and McNeil’s approach was used to compare the AUCs of the indices. , compared with the AUC of BMI; , compared with the AUC of WC. The bold indicates the highest AUC value among the indices.